Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation

BACKGROUND: High intensity treatments such as hematopoietic cell transplantation (HCT) can be curative for patients with hematologic malignancies, but this needs to be balanced by the high risk of nonrelapse mortality (NRM) during the first 2 years after HCT. Sarcopenia (low muscle mass) is associat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Natl Cancer Inst
Autori principali: Armenian, Saro H, Xiao, Meisi, Berano Teh, Jennifer, Lee, Brandyn, Chang, Howard A, Mascarenhas, Kristen, Lee, Sean, Iukuridze, Alex, Xie, Jack J, Scott, Jessica M, Jones, Lee W, Lennie Wong, F, Forman, Stephen J, Nakamura, Ryotaro
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695315/
https://ncbi.nlm.nih.gov/pubmed/30951603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy231
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi